Low-margin pricing:
Medicines sold at ₹80-100 against a market price of ₹200-250
Our Solutions
Delivering reliable healthcare solutions with quality medicines, trusted guidance, and patient-focused services. We are committed to improving access, affordability, and care for every individual and family we serve.
Market Challenges
Exploitative margins:
Medicines costing ₹50 sold for ₹200-250
Urban-centric chains:
Rural & semi-urban communities left severely underserved
Affordability crisis:
Low-income families forced to overpay or skip treatment
No quality-affordable balance:
Players either cut quality or inflate prices
Our Solution
No middlemen:
Direct hospital & distributor tie-ups to keep costs minimal
Last-mile reach:
Expanding into underserved district towns & villages across Telangana & Andhra Pradesh
Government partnerships:
Tie-ups with government hospitals to ensure maximum accessibility
Core Offerings
Affordable Generic & Branded Medicines:
A wide range of high-quality medicines offered at significantly lower margins.
A wide range of high-quality medicines offered at significantly lower margins.
End-to-End Pharmaceutical Supply:
Retail + wholesale distribution to hospitals, clinics, and consumers.
Retail + wholesale distribution to hospitals, clinics, and consumers.
Direct Procurement Model:
Sourcing directly from manufacturers to reduce costs and eliminate intermediaries.
Sourcing directly from manufacturers to reduce costs and eliminate intermediaries.
Future Proprietary Products:
Launch of exclusive, WHO-supported patented medicines under Devaki Pharmacy brand.
Launch of exclusive, WHO-supported patented medicines under Devaki Pharmacy brand.
Why We Are Better
01
Lowest Margins, Highest Integrity
Medicines priced nearly at cost, ensuring affordability without compromising quality.
03
No Middlemen
Direct sourcing keeps costs transparent and margins minimal.
05
Government-Backed Reach
Partnerships with government hospitals for scale and credibility.
02
Last-Mile Focus
Targeting districts and villages that established chains ignore.
04
Proprietary Innovation
WHO-aligned, high-quality pharmaceutical products developed in-house.
06
First-Mover Advantage
Affordable quality medicines in underserved South Indian markets.